Bliss GVS Pharma gains 5% on bagging EU GMP certification for two units

Shares of smallcap firm Bliss GVS Pharma gained up to 5 per cent to hit an intraday high of Rs 138.20 a piece on Monday after the pharma company's manufacturing sites received GMP certification

drugs, medicine, pharmaceuticals
Photo: Shutterstock
SI Reporter New Delhi
2 min read Last Updated : Nov 25 2024 | 10:54 AM IST
Shares of smallcap firm Bliss GVS Pharma gained up to 5 per cent to hit an intraday high of Rs 138.20 a piece on Monday after the pharma company’s manufacturing sites received GMP (Good Manufacturing Practice) certification from the European regulatory authority. 
 
“We are pleased to inform you that the Company’s manufacturing facility situated at Plot No. 11, Dewan Udyog Nagar, Aliyali Village, Palghar, 401404, India and Survey No. 43-44, Vevoor Village, 401404, India, has successfully received a Certificate of GMP Compliance from the National Agency for Medicines and Medical Devices of Romania (NAMMDR),” the company said in an exchange filing on Saturday. 
 
The European regulator issued the certification following an EU GMP inspection that took place on 30th November and 1st December 2023.

Q2 results

Bliss GVS Pharma reported a 2.8 per cent year-on-year decrease in consolidated revenue, which stood at Rs 217 crore for the second quarter of financial year 2024-2025. However, on a quarterly basis, the company saw a significant 18 per cent increase in revenue compared to the previous quarter.
 
Net profit for the company dropped 41 per cent year-on-year to Rs 25 crore in Q2FY25 compared with Rs 43 crore in the same quarter last year. On a quarterly basis, net profit increased by 13.6 per cent compared to the previous three months.

Bliss GVS Pharma share price history

The company’s stock has underperformed the market year to date as it has risen 8 per cent, while slipping 8 per cent in the last one year. In comparison BSE Sensex has risen 11 per cent year to date and 21 per cent in a year. 
 
The company has a total market capitalisation of Rs 1,414.19 crore. Bliss GVS Pharma shares are trading at a price to earnings multiple of 30.24 times and at an earning per share of Rs 4.35. 
 
At 10:45 AM; the shares of the company were trading 2.28 per cent higher at Rs 134.50 a piece. By comparison, the BSE Sensex was up 1.55 per cent at 80,343.97 level. 
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Buzzing stocksMarkets Sensex NiftyBSE NSE

First Published: Nov 25 2024 | 10:54 AM IST

Next Story